Prostate Cancer Risk Stratification: Utilizing IsoPSA with mpMRI

Join Urologic Oncologist Dr. Tarik Benidir for an in-depth presentation on how IsoPSA and mpMRI can complement each other to improve prostate biopsy decision making. This session will review clinical evidence on combining IsoPSA results with PI-RADS scoring, including the test’s utility for refining risk assessment in men with equivocal PI-RADS 3 results and identifying hidden MRI invisible csPCa lesions in PI-RADS 1 2 findings. Dr. Benidir will discuss the use of MRI with other ancillary tests, guideline-based patient selection, interpretation of IsoPSA results, and real-world cases. Dr. Benidir’s insights will educate clinicians on how to improve early detection of csPCa and enhancing the patient’s experience.